ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.05%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -41.97% | -35.82% | 908.80% | -11.64% | -67.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -41.97% | -35.82% | 908.80% | -11.64% | -67.59% |
| Cost of Revenue | -56.24% | -57.21% | 30.64% | -46.38% | -58.59% |
| Gross Profit | 135.09% | 1,022.67% | 126.40% | 181.44% | -91.24% |
| SG&A Expenses | -48.08% | -48.99% | 9.59% | 9.95% | 6.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -49.68% | -50.68% | 9.45% | -4.41% | -15.19% |
| Operating Income | 50.99% | 53.28% | 8.32% | 3.00% | -16.60% |
| Income Before Tax | 41.70% | 44.75% | 0.56% | -2.87% | -25.33% |
| Income Tax Expenses | -85.92% | -100.00% | 247.72% | 236.30% | 213.53% |
| Earnings from Continuing Operations | 50.57% | 52.78% | -103.95% | -94.83% | -116.79% |
| Earnings from Discontinued Operations | -100.00% | 325.16% | 357.39% | 535.78% | 848.45% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.21% | 72.37% | -50.25% | -57.55% | -82.79% |
| EBIT | 50.99% | 53.28% | 8.32% | 3.00% | -16.60% |
| EBITDA | 55.67% | 59.27% | 6.92% | 1.14% | -22.40% |
| EPS Basic | 82.46% | 92.12% | -4.83% | -20.36% | -47.32% |
| Normalized Basic EPS | 81.90% | 80.37% | 40.09% | 28.72% | 4.41% |
| EPS Diluted | 82.38% | 92.03% | -5.15% | -20.63% | -47.55% |
| Normalized Diluted EPS | 81.90% | 80.37% | 40.09% | 28.72% | 4.41% |
| Average Basic Shares Outstanding | 339.82% | 324.38% | 94.34% | 68.03% | 40.29% |
| Average Diluted Shares Outstanding | 339.82% | 324.38% | 94.34% | 68.03% | 40.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |